FDA issues “sharply worded” warning to heart device manufacturer. In continuing coverage, the New York Times (1/16, B2, Meier, Subscription Publication, 1.68M) reports that the Food and Drug Administration “on Tuesday released a sharply worded warning letter to St. Jude Medical, in which it said it might soon fine or take other actions against the… Continue Reading